Abstract:Human epidermal growth factor receptor 2 (HER2)/Neu is overexpressed in 20-30% of breast cancers and associated with aggressive phenotypes and poor prognosis. For deciphering the role of HER2/Neu in breast cancer, mouse mammary tumor virus (MMTV)-Her2/neu transgenic mice that develop mammary tumors resembling human HER2-subtype breast cancer have been established. Several recent studies have revealed that HER2/Neu is overexpressed in and regulates self renewal of breast tumor-initiating cells (TICs). However, in the MMTV-Her2/neu transgenic mouse model, the identity of TICs remains elusive, despite previous studies showing supportive evidence for existence of TICs in Her2/neu-induced mammary tumors. Through systematic screening and characterization, we identified that surface markers CD49f, CD61 and ESA were aberrantly overexpressed in Her2-overexpressing mammary tumor cells. Analysis of these markers and CD24 detected anomalous expansion of the luminal progenitor population in preneoplastic mammary glands of Her2/neu transgenic mice, indicating that aberrant luminal progenitors originated in Her2-induced mammary tumors. The combined markers, CD49f and CD61, further delineated the CD49f(high)CD61(high)-sorted fraction as a TIC-enriched population, which displayed increased tumorsphere formation ability, enhanced tumorigenicity both in vitro and in vivo and drug resistance to pacitaxel and doxorubicin. Moreover, the TIC-enriched population manifested increased transforming growth factor-beta (TGF beta) signaling and exhibited gene expression signatures of stemness, TGF beta signaling and epithelial-to-mesenchymal transition. Our findings that self-renewal and clonogenicity of TICs were suppressed by pharmacologically inhibiting the TGF beta signaling further indicate that the TGF beta pathway is vital for maintenance of the TIC population. Finally, we showed that the integrin-beta 3 (CD61) signaling pathway was required for sustaining active TGF beta signaling and self-renewal of TICs. We for the first time developed a technique to highly enrich TICs from mammary tumors of Her2/neu transgenic mice, unraveled their properties and identified the cooperative integrin-beta 3-TGF beta signaling axis as a potential therapeutic target for HER2-induced TICs. Oncogene (2012) 31, 2614-2626; doi:10.1038/onc.2011.439; published online 26 September 2011

A NIK-IKKα Module Expands ErbB2-Induced Tumor-Initiating Cells by Stimulating Nuclear Export of P27/kip1

Nuclear Factor-κB Enhances ErbB2-Induced Mammary Tumorigenesis and Neoangiogenesis in Vivo

high expression of NF-κB inducing kinase in the bulge region of hair follicle induces tumor

Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer

Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model.

IκB Kinase Ε is an NFATc1 Kinase That Inhibits T Cell Immune Response.

Cytoplasmic Expression of P21cip1/waf1 is Correlated with IKKbeta Overexpression in Human Breast Cancers.

NIK is a component of the EGF/heregulin receptor signaling complexes

Integrin-linked Kinase Overexpression Promotes Epithelial-Mesenchymal Transition Via Nuclear Factor-Κb Signaling in Colorectal Cancer Cells.

Suppression of Angiogenesis and Tumor Growth by Selective Inhibition of Angiopoietin-2

NIK is a component of the EGF|[sol]|heregulin receptor signaling complexes

Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis

Activation of Akt-1 (PKB-α) Can Accelerate ErbB-2-Mediated Mammary Tumorigenesis but Suppresses Tumor Invasion

CD49f and CD61 Identify Her2/neu-induced Mammary Tumor-Initiating Cells That Are Potentially Derived from Luminal Progenitors and Maintained by the Integrin–tgfβ Signaling

IκB Kinase ɛ Expression in Pancreatic Ductal Adenocarcinoma

Interaction Between Nuclear Insulin Receptor Substrate-2 and NF-κB in IGF-1 Induces Response in Breast Cancer Cells.

Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells

AZI2 mediates TBK1 activation at unresolved selective autophagy cargo receptor complexes with implications for CD8 T-cell infiltration in breast cancer

I Kappa B Kinase A Functions As A Tumor Suppressor in Epithelial-Derived Tumors Through an Nf-Kappa B-Independent Pathway

IKKα Inactivation Promotes Kras-initiated Lung Adenocarcinoma Development Through Disrupting Major Redox Regulatory Pathways.

IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines.